New Anticancer Agents: Design, Synthesis and Evaluation

Vadim Pokrovsky1, Raffaele Addeo2, Mauro Coluccia3

  • 1Laboratory of Combined Treatment, N.N. Blokhin National Medical Research Center of Oncology of Ministry of Health of Russian Federation, 115478 Moscow, Russia.

Insights

Tumorigenesis, the development of tumors, is a complex pathological process. Understanding its fundamental mechanisms is crucial for developing effective cancer therapies.

Area of Science:

  • Oncology
  • Pathology
  • Molecular Biology

Background:

  • Tumorigenesis represents a fundamental yet intricate pathological process.
  • The study of cancer development involves understanding complex molecular and cellular changes.

Discussion:

  • Investigating the core mechanisms of tumorigenesis is essential for advancing cancer research.
  • Elucidating these processes aids in identifying novel therapeutic targets.

Key Insights:

  • The complexity of tumorigenesis necessitates a multi-faceted research approach.
  • Understanding cancer initiation and progression is key to improving patient outcomes.

Outlook:

  • Future research will focus on unraveling the intricate pathways of tumorigenesis.
  • This knowledge will drive the development of targeted cancer treatments.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K